Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.

doi:10.1089/gtmb.2014.0061

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.

Genetic testing and molecular biomarkers - 1 Aug 2014

Bayramoglu Aysegul, Gunes Hasan Veysi, Metintas Muzaffer, Degirmenci Irfan, Guler Halil Ibrahim, Ustuner Cengiz, Musmul Ahmet

Abstract excerpt

AIM: The aim of this study was to investigate the polymorphism frequency of plasminogen activator inhibitor-1 (PAI-1) (rs1799889) 4G/5G in patients with lung cancer. METHODS: In this study, 286 genomic DNAs (154 lung cancer patients+132 subjects without lung cancer) were analyzed. Polymorphisms were determined by using the polymerase chain reaction (PCR) method, with 4G and 5G allele-specific primers. PCR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Lung Neoplasms

Share to Neoplasm Proteins

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Genetic

Share to Turkey

Source

Open in PubMed Open full text

Identifiers

PMID: 24955483
DOI: 10.1089/gtmb.2014.0061
PMCID: PMC4120932

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.PMID 24955483Read ↗

PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.Semantic proximity Read ↗

Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.Semantic proximity Read ↗

Association Between Plasminogen Activator Inhibitor-1-675 4G/5G Insertion/Deletion Polymorphism and Chronic Obstructive Pulmonary Disease.Semantic proximity Read ↗

PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population.Semantic proximity Read ↗

Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.Semantic proximity Read ↗

The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.Semantic proximity Read ↗

Clinicopathological significance of plasminogen activator inhibitor-1 promoter 4G/5G polymorphism in breast cancer: a meta-analysis.Semantic proximity Read ↗

Glutathione S-transferase P1, gene-gene interaction, and lung cancer susceptibility in the Chinese population: An updated meta-analysis and review.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 gene promoter 4G/5G polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study.Semantic proximity Read ↗

PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer.Semantic proximity Read ↗

4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.